Sacral Erector Spinae Plane Blocks in Pediatric Patients

Postoperative Pain Clinical Trial

Official title:

Retrospective Analyses of Sacral Erector Spinae Plane Blocks in Pediatric Patients: Is it Time to Discuss the Necessity of Caudal Block

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05415046
• Other study ID #: GOKAEK-2021/6.04
• Status: Completed
• Start date: June 15, 2022
• Est. completion date: July 8, 2022

Study information

• Verified date: August 2022
• Source: Kocaeli University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients who were operated by Department of Pediatric Surgery and who received sacral erector spinae plane blocks as a part of postoperative analgesia management will be scanned.

Description:

Erector spinae plane block (ESPB) is a safe and effective regional anesthesia technique in pediatric patients and can be performed at any level of the thoracic and lumbar vertebrae. In addition, ESPB can be performed at the sacral region in the midline. In pediatric patients, sacral ESPB provides effective analgesia and this method can replace caudal blocks.

This study aims to investigate the efficacy of sacral ESPB retrospectively. Demographical data of the patient, indication/surgery type, total volume applied, additional analgesic use, type of the analgesic if used will be investigated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: July 8, 2022
• Est. primary completion date: July 7, 2022
• Gender: All
• Age group: 1 Month to 18 Years

Eligibility

Inclusion Criteria:

• Patients who were operated by Department of Pediatric Surgery

Exclusion Criteria:

• Incomplete patient forms

Related Conditions & MeSH terms

• Pain, Postoperative
• Postoperative Pain

Intervention

Procedure:
• Sacral ESPB
Erector spinae plane block performed with 0,25% bupivacaine (1 mL/kg-max 20mL), under general anesthesia before the start of the surgery.

Locations

Country	Name	City	State
Turkey	Kocaeli University Hospital	Kocaeli

Sponsors (1)

Lead Sponsor	Collaborator
Kocaeli University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Face, Legs, Activity, Cry, Consolability (FLACC) Scale	The scale is scored in a range of 0-10 with 0 representing no pain (meaning a better outcome). The scale has five criteria, which are each assigned a score of 0, 1 or 2.	Postoperative 24th hour.
Primary	Rescue analgesic-paracetamol	The need and amount of the IV paracetamol given	During the postoperative 24th hour.
Primary	Rescue analgesic-ibuprofen	The need and amount of the oral ibuprofen given	During the postoperative 24th hour.